newsFDA approval could shape liver disease treatment landscape15 March 2024 | By Catherine Eckford (European Pharmaceutical Review)A novel liver therapy authorised under US Food and Drug Administration (FDA) Accelerated Approval, is a potential game-changer in the NASH treatment space.